{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T03:50:13Z","timestamp":1649217013821},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1979,1,1]],"date-time":"1979-01-01T00:00:00Z","timestamp":283996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1979]]},"DOI":"10.1007\/bf00558430","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T18:15:50Z","timestamp":1100888150000},"page":"293-298","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of once and twice daily administration of sotalol in the treatment of hypertension"],"prefix":"10.1007","volume":"15","author":[{"given":"I.","family":"Parvinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Paukkala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0773.1976.tb03162.x","volume":"39","author":"M. Anttila","year":"1976","unstructured":"Anttila, M., Arstila, M., Pfeffer, M., Tikkanen, R., Vollinkosti, V., Sundquist, H.: Human Pharmacokinetics of Sotalol. Acta Pharmacol. Toxicol.39, 118 (1976)","journal-title":"Acta Pharmacol. Toxicol."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00606550","volume":"9","author":"H. C. Brown","year":"1976","unstructured":"Brown, H. C., Carruthers, S. G., Kelly, J. G., McDevitt, D. G., Shanks, R. G.: Observations of the Efficacy and Pharmacokinetics of Sotalol after Oral Administration. Europ. J. clin. Pharmacol.9, 367?372 (1976)","journal-title":"Europ. J. clin. Pharmacol."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/bmj.1.6016.990","volume":"I","author":"A. P. Douglas-Jones","year":"1976","unstructured":"Douglas-Jones, A. P., Cruickshank, J. M.: Once daily Dosing with Atenolol in Patients with Mild or Moderate Hypertension. Br. Med. J.1976\/I, 990?991","journal-title":"Br. Med. J."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1185\/03007997609112010","volume":"4","author":"R. Gabriel","year":"1977","unstructured":"Gabriel, R.: Control of Hypertension with Single Daily Doses of Sotalol Hydrochloride. Curr. Med. Res. Opin.4, 739 (1977)","journal-title":"Curr. Med. Res. Opin."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/jps.2600600607","volume":"60","author":"E. R. Garrett","year":"1971","unstructured":"Garrett, E. R., Schnelle, K.: Separation and Spectrofluometric Assay of the Beta-adrenergic Blocker Sotalol from Blood and Urine. J. Pharm. Sci.60, 833 (1971)","journal-title":"J. Pharm. Sci."},{"key":"CR6","first-page":"39","volume":"16","author":"M. S. Gatley","year":"1968","unstructured":"Gatley, M. S.: To be taken as directed. J. R. Coll. Gen. Pract.16, 39 (1968)","journal-title":"J. R. Coll. Gen. Pract."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cpt1977222125","volume":"22","author":"R. B. Haynes","year":"1977","unstructured":"Haynes, R. B., Sackett, D. L., Taylor, D. W., Roberts, R. S., Johnson, A. L.: Manipulation of the Therapeutic regimen to Improve Compliance: Conceptions and Misconceptions. Clin. Pharmacol. Ther.22, 125 (1977)","journal-title":"Clin. Pharmacol. Ther."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2125.1977.tb00780.x","volume":"4","author":"T. A. Jeffers","year":"1977","unstructured":"Jeffers, T. A., Webster, J., Petric, J. C., Barker, N. P.: Atenolol Once daily in Hypertension. Br. J. clin. Pharmacol.4, 523 (1977)","journal-title":"Br. J. clin. Pharmacol."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2125.1977.tb00687.x","volume":"4","author":"D. G. McDevitt","year":"1977","unstructured":"McDevitt, D. G., Shanks, R. G.: Evaluation of Once daily Sotalol Administration in Man. Br. J. clin. Pharmacol.4, 153 (1977)","journal-title":"Br. J. clin. Pharmacol."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/bmj.1.5638.218","volume":"I","author":"A. M. W. Porter","year":"1969","unstructured":"Porter, A. M. W.: Drug Defaulting in General Practice. Br. med. J.1969\/I, 218","journal-title":"Br. med. J."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bmj.2.5411.725","volume":"II","author":"B. N. C. Prichard","year":"1964","unstructured":"Prichard, B. N. C., Gillam, P. M. S.: Use of propranolol in the Treatment of Hypertension. Br. med. J.1964\/II, 725","journal-title":"Br. med. J."},{"key":"CR12","unstructured":"Prichard, B. N. C., Boakes, A. J.: The Use of Sotalol in the Treatment of Hypertension. Advance in Beta-Adrenergic Blocking Therapy ? Sotalol. Vol III. A. G. Snart (ed.) pp. 7?24, 1974"},{"key":"CR13","unstructured":"Shanks, R. G.: Methods in Drug Evaluation. P. Mantegazza and F. Picinini, (eds.), pp. 118?126 (1966)"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/bmj.2.6026.46-c","volume":"II","author":"H. L. Shaw","year":"1976","unstructured":"Shaw, H. L.: Once Daily Treatment of Hypertension. Br. med. J.1976\/II, 46?47","journal-title":"Br. med. J."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00003495-197407010-00006","volume":"7","author":"F. O. Simpson","year":"1974","unstructured":"Simpson, F. O.: Beta Adrenergic Blocking Drugs in Hypertension. Drugs7, 85?105 (1974)","journal-title":"Drugs"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cpt1974163part1465","volume":"16","author":"H. Sundquist","year":"1974","unstructured":"Sundquist, H., Anttila, M., Arstila, M.: Antihypertensive effects of practolol and sotalol. Clin. Pharmacol. Ther.16, 465 (1974)","journal-title":"Clin. Pharmacol. Ther."},{"key":"CR17","volume-title":"Pharmacokinetics and Hypertensive Effect of the Beta Blockers Sotalol","author":"H. Sundquist","year":"1976","unstructured":"Sundquist, H.: Pharmacokinetics and Hypertensive Effect of the Beta Blockers Sotalol. Turku: Jaakko-Taara Oy 1976"},{"key":"CR18","first-page":"688","volume":"21","author":"J. Tuomilehto","year":"1977","unstructured":"Tuomilehto, J., Arstila, M., Savilahti, R., Sundquist, H.: Sotalol and a Combination of Hydrochlorothiazide and Spironolactone in the Treatment of Hypertension with a Single Daily Dose. Curr. Ther. Res.21, 688 (1977)","journal-title":"Curr. Ther. Res."},{"key":"CR19","first-page":"5455","volume":"51","author":"M. J. West","year":"1976","unstructured":"West, M. J., Sleight, P., Honour, A. J.: Clinical Trial of the Beta Adrenoceptor Blocking Agent Tolamolol with the Use of 24 hour Blood Pressure Recordings. Clin. Sci. Mol. Med.51, 5455 (1976)","journal-title":"Clin. Sci. Mol. Med."},{"key":"CR20","first-page":"877","volume":"II","author":"A. Westerlund","year":"1976","unstructured":"Westerlund, A., Hansson, L.: Once daily Treatment of Hypertension. Br. med. J.1976\/II, 877","journal-title":"Br. med. J."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-2125.1976.tb00638.x","volume":"3","author":"M. Wilson","year":"1976","unstructured":"Wilson, M., Morgan, G., Morgan, T.: The Effect on Blood Pressure of Beta-Adrenoceptor Blocking Drugs Administered Once Daily and their Duration of Action when Therapy is ceased. Br. J. clin. Pharmacol.3, 857 (1976)","journal-title":"Br. J. clin. Pharmacol."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000136287","volume":"7","author":"R. Zacest","year":"1972","unstructured":"Zacest, R., Koch-Weser, J.: Relation of Propranolol Plasma Level to Beta Blockade during Oral Therapy. Pharmacology7, 178 (1972)","journal-title":"Pharmacology"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM197203232861201","volume":"286","author":"R. Zacest","year":"1972","unstructured":"Zacest, R., Gilmore, E., Koch-Weser, J.: Treatment of Essential Hypertension with Combined Vasodilation and Beta-adrenergic Blockade. New Engl. Med. J.286, 617 (1972)","journal-title":"New Engl. Med. J."}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00558430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00558430\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00558430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T00:08:24Z","timestamp":1554422904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00558430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1979]]}},"alternative-id":["BF00558430"],"URL":"https:\/\/doi.org\/10.1007\/bf00558430","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1979]]}}}